NEWISH TECHNOLOGY (BEIJING) CO., LTD. (20250082740). USE OF CXCL14
USE OF CXCL14
Organization Name
NEWISH TECHNOLOGY (BEIJING) CO., LTD.
Inventor(s)
Jiandong Jiang of Beijing (CN)
USE OF CXCL14
This abstract first appeared for US patent application 20250082740 titled 'USE OF CXCL14
Original Abstract Submitted
the disclosure relates to the field of molecular biology, and in particular relates to the use of cxcl 14. according to the present invention, different antigen proteins are transferred to the surface of a dc cell by means of the chemotactic binding capacity of cxcl 14 and surface receptors of immune cells such as dc cells. a chemokine of cxcl14 can effectively induce the binding of an antigen molecule to a specific immune cell at the n-terminal of an antigen protein, such that the cross presentation effect of the antigen molecule is greatly enhanced, and cxcl14 can finally induce a stronger specific immune response of the antigen molecule.
- NEWISH TECHNOLOGY (BEIJING) CO., LTD.
- Hailong Qi of Beijing (CN)
- Xudong Wang of Beijing (CN)
- Jiandong Jiang of Beijing (CN)
- Lulu Wang of Beijing (CN)
- Defang Liu of Beijing (CN)
- Yanling Yao of Beijing (CN)
- Xiaofang Wang of Beijing (CN)
- Zhongjie Sun of Beijing (CN)
- A61K39/00
- A61P35/00
- A61P37/04
- C07K14/52
- C12N15/62
- C12N15/85
- CPC A61K39/001142